Clinical and biological markers of severity in myasthenia gravis

Key Points

• Severity of myasthenia gravis is linked to specific biological markers and clinical symptoms, indicating varied patient experiences.
• Biological markers can effectively predict the severity of symptoms, leading to better individual treatment plans.
• Assessment across multiple patients highlights the importance of recognizing varied clinical presentations of myasthenia gravis.
• Understanding these markers may enable physicians to tailor interventions more precisely for affected individuals.